Freestone Capital Holdings’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,633
| Closed | -$120K | – | 1190 |
|
|
2020
Q4 | $120K | Sell |
1,633
-618
| -27% | -$39.7K | 0.01% | 406 |
|
|
2020
Q3 | $123K | Buy |
+2,251
| New | +$140K | 0.01% | 375 |
|
|
2020
Q2 | – | Sell |
-3,931
| Closed | -$241 | – | 396 |
|
|
2020
Q1 | $241 | Sell |
3,931
-10,384
| -73% | -$769K | 0.01% | 329 |
|
|
2019
Q4 | $1.26K | Sell |
14,315
-5,556
| -28% | -$469K | 0.03% | 234 |
|
|
2019
Q3 | $1.5K | Sell |
19,871
-5,250
| -21% | -$426K | 0.04% | 206 |
|
|
2019
Q2 | $2.15K | Sell |
25,121
-104,636
| -81% | -$10.3M | 0.05% | 155 |
|
|
2019
Q1 | $14M | Buy |
129,757
+33,130
| +34% | +$3.3M | 0.83% | 28 |
|
|
2018
Q4 | $8.18M | Sell |
96,627
-44,092
| -31% | -$4.25M | 0.55% | 48 |
|
|
2018
Q3 | $13.8M | Sell |
140,719
-4,244
| -3% | -$459K | 0.09% | 39 |
|
|
2018
Q2 | $16.8M | Sell |
144,963
-21,785
| -13% | -$2.39M | 0.11% | 37 |
|
|
2018
Q1 | $16.5M | Buy |
166,748
+21,392
| +15% | +$2.17M | 0.96% | 35 |
|
|
2017
Q4 | $15.2M | Sell |
145,356
-2,125
| -1% | -$233K | 1.05% | 29 |
|
|
2017
Q3 | $16.6M | Buy |
147,481
+4,731
| +3% | +$515K | 1.18% | 22 |
|
|
2017
Q2 | $16M | Buy |
142,750
+441
| +0.3% | +$49.8K | 1.25% | 24 |
|
|
2017
Q1 | $16.6M | Buy |
142,309
+57,409
| +68% | +$6.35M | 1.28% | 28 |
|
|
2016
Q4 | $8.94M | Sell |
84,900
-4,105
| -5% | -$430K | 0.77% | 32 |
|
|
2016
Q3 | $9.84M | Sell |
89,005
-31,162
| -26% | -$4.13M | 0.9% | 30 |
|
|
2016
Q2 | $17.5M | Buy |
120,167
+7,257
| +6% | +$1.03M | 1.71% | 21 |
|
|
2016
Q1 | $16.2M | Sell |
112,910
-5,909
| -5% | -$839K | 1.7% | 25 |
|
|
2015
Q4 | $18.4M | Buy |
118,819
+111,181
| +1,456% | +$16.2M | 1.9% | 14 |
|
|
2015
Q3 | $1.09M | Buy |
+7,638
| New | +$1.07M | 0.12% | 140 |
|
Other funds holding TARO
KAM
BIP
EP
